{
  "trial_id": "NCT02834663",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, type 2 diabetes mellitus duration, best corrected visual acuity (BCVA), central retinal thickness (CRT), presence of nonproliferative diabetic retinopathy (NPDR), presence of diabetic macular edema (DME), history of hypertension, history of glaucoma.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Duration of Diabetes Mellitus(DM) (year)",
          "type 2 diabetes mellitus duration"
        ],
        [
          "BCVA (ETDRS letters)",
          "best corrected visual acuity (BCVA)"
        ],
        [
          "CRT (um)",
          "central retinal thickness (CRT)"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race (NIH/OMB)",
        "HbA1c(%)",
        "Total microaneurysms (number)",
        "Microaneurysm-turnover",
        "Perifoveal non-perfused area (mm^2)"
      ],
      "remaining_candidate_features": [
        "presence of nonproliferative diabetic retinopathy (NPDR)",
        "presence of diabetic macular edema (DME)",
        "history of hypertension",
        "history of glaucoma."
      ]
    },
    "processed-gen-response": "Age, gender, type 2 diabetes mellitus duration, best corrected visual acuity (BCVA), central retinal thickness (CRT), presence of nonproliferative diabetic retinopathy (NPDR), presence of diabetic macular edema (DME), history of hypertension, history of glaucoma."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Duration of Diabetes, Baseline HbA1c, Best Corrected Visual Acuity (BCVA), Central Macular Thickness (CMT), Blood Pressure,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Duration of Diabetes Mellitus(DM) (year)",
          "Duration of Diabetes"
        ],
        [
          "HbA1c(%)",
          "Baseline HbA1c"
        ],
        [
          "BCVA (ETDRS letters)",
          "Best Corrected Visual Acuity (BCVA)"
        ],
        [
          "CRT (um)",
          "Central Macular Thickness (CMT)"
        ]
      ],
      "remaining_reference_features": [
        "Race (NIH/OMB)",
        "Total microaneurysms (number)",
        "Microaneurysm-turnover",
        "Perifoveal non-perfused area (mm^2)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Blood Pressure"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Duration of Diabetes, Baseline HbA1c, Best Corrected Visual Acuity (BCVA), Central Macular Thickness (CMT), Blood Pressure"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Diabetes Type, Diabetes Duration, HbA1c, Systolic Blood Pressure, Diastolic Blood Pressure, Body Mass Index, Retinopathy Severity, Best Corrected Visual Acuity, Central Macular Thickness.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Duration of Diabetes Mellitus(DM) (year)",
          "Diabetes Duration"
        ],
        [
          "HbA1c(%)",
          "HbA1c"
        ],
        [
          "BCVA (ETDRS letters)",
          "Best Corrected Visual Acuity"
        ],
        [
          "CRT (um)",
          "Central Macular Thickness."
        ]
      ],
      "remaining_reference_features": [
        "Race (NIH/OMB)",
        "Total microaneurysms (number)",
        "Microaneurysm-turnover",
        "Perifoveal non-perfused area (mm^2)"
      ],
      "remaining_candidate_features": [
        "Diabetes Type",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Body Mass Index",
        "Retinopathy Severity"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Diabetes Type, Diabetes Duration, HbA1c, Systolic Blood Pressure, Diastolic Blood Pressure, Body Mass Index, Retinopathy Severity, Best Corrected Visual Acuity, Central Macular Thickness."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, type of diabetes, duration of diabetes, best corrected visual acuity, central retinal thickness, nonproliferative diabetic retinopathy severity, presence of hypertension, presence of glaucoma.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Duration of Diabetes Mellitus(DM) (year)",
          "duration of diabetes"
        ],
        [
          "BCVA (ETDRS letters)",
          "best corrected visual acuity"
        ],
        [
          "CRT (um)",
          "central retinal thickness"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race (NIH/OMB)",
        "HbA1c(%)",
        "Total microaneurysms (number)",
        "Microaneurysm-turnover",
        "Perifoveal non-perfused area (mm^2)"
      ],
      "remaining_candidate_features": [
        "type of diabetes",
        "nonproliferative diabetic retinopathy severity",
        "presence of hypertension",
        "presence of glaucoma."
      ]
    },
    "processed-gen-response": "Age, sex, type of diabetes, duration of diabetes, best corrected visual acuity, central retinal thickness, nonproliferative diabetic retinopathy severity, presence of hypertension, presence of glaucoma."
  }
}